// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Lessons learnt from National HIV ‘teaching’ week

Kevin Turner - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Barriers to attending cervical screening amongst ethnic minority women: a qualitative analysis

Harsha Dhokia - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Knowledge, practices and misconceptions about vulval skin care across different age groups of women attending a sexual health clinic

Roberta Shaw - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Evaluation of inpatient Pelvic Inflammatory Disease in a semi- urban county

Sumt Bhaduri - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

To wait or not to wait? That is the question

Nisha Talwar - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Successful management of persistent vulvovaginal yeast infection using oral voriconazole

Georgina Morris - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

UK-109496

Getting to zero – the butterfly effect

Hayley Holloway - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

How is economic evidence conceptualised when evaluating sexual health interventions and the control of sexually transmitted infections (STIs)? – A systematic review

Sonja C. M. Bloch - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Offer and uptake of HPV vaccination in men who have sex with men

Cecilia Priestley - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Online home testing – a review of service users and outcomes

Reiss Dhillon - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

When should women attending General Practice be offered STI screening and sexual health advice? A review of national guidance

Natalie Edelman - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Take me home! – an initiative to improve GC TOC in a countywide rural sexual health service

Michelle Creed - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Impact of clearer SMS text messaging on test to treatment turnaround times (TATs) for Chlamydia Trachomatis (CT)

Merle Symonds - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Health care provider FGM routine enquiry survey

Shashirekha Vijayappa - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Referrals to a sexual health clinic – are they appropriate?

Asawari Gupta - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Identifying opportunities to improve chlamydia screening pathways in Derby City and Derbyshire

Laura Spowage - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

To what extent are community pharmacists "Spotting the Signs" and acting appropriately according to the child sexual exploitation safeguarding training?

Sandhya Garg - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

An evaluation study of the experiences of deaf sign language users who have accessed sexual health services in South England

Damian Brewer - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Symptom-based M genitalium testing: a prudent approach?

Branwen Davies - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Implementation of a local pathway for Mycoplasma Genitalium testing

Rebecca Marchant - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved